Effectiveness of an opting-out strategy for HIV testing: Evaluation of 4 years of standard HIV testing in a STI clinic

Sexually Transmitted Infections

Volumn 85, Issue 3, 2009, Pages 226-230

  Dukers Muijrers, Nicole H T M ^a,b   Niekamp, A M ^a,b   Vergoossen, M M H ^a   Hoebe, C J P A ^a,b  

^a South Limburg Public Health Service   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; FEMALE; HEALTH CARE POLICY; HETEROSEXUAL MALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; MEDICAL PRACTICE; PATIENT COUNSELING; PRIORITY JOURNAL; RISK ASSESSMENT; SCREENING TEST; SEXUALLY TRANSMITTED DISEASE; VIRUS DIAGNOSIS; VIRUS EXAMINATION;

ADULT; AMBULATORY CARE FACILITIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MASS SCREENING; NETHERLANDS; PATIENT ACCEPTANCE OF HEALTH CARE; REFUSAL TO PARTICIPATE; RISK FACTORS; SEXUAL BEHAVIOR;

EID: 66449097379     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sti.2008.033191     Document Type: Article

References (21)

1. World Health Organization. Increasing access to knowledge of HIV status. Conclusions of a WHO consultation, 3-4 December 2001. Geneva: WHO, 2002.
2. Glynn M, Rhodes P. What is really happening with HIV trends in the United States? Modeling the national epidemic. National HIV Prevention Conference June 2005. Atlanta (abstract T1-B11-13).
3. Marks G, Crepaz N, Janssen RS. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS 2006;20:1447-1450 (Pubitemid 43948252)
4. World Health Organization/UNAIDS. UNAIDS/WHO policy statement on HIV testing. WHO/UNAIDS, 2004. http://www.who.int/ethics/topics/en/hivtestingpolicy- who-unaids-en-2004.pdf (accessed 25 January 2009).
5. Branson BM, Handsfield HH, et al, Centers for Disease Control and Prevention (CDC). Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep 2006;55:1-17.
6. van Veen MG, Koedijk FDH, van den Broek IVF, et al. Sexually Transmitted Infections in the Netherlands in 2006. RIVM report 210261003/2007, Bilthoven, The Netherlands. http://www.rivm.nl/bibliotheek/rapporten/210261003.pdf (accessed 25 January 2009).
7. http://www.soaaids-professionals.nl/epidemiologie/recente-cijfers (accessed 25 January 2009).
8. Annual report 2007. HIV Monitoring Foundation, April 2008. http://www.hiv-monitoring.nl/-site1134/images/SR-2007---Complete-r.pdf (accessed 25 January 2009).
9. Hospers HJ, Dörfler TT, Zuilhof W. Monitoronderzoek 2006. Amsterdam: Schorer, 2006.
10. Van der Bij AK, Dukers NH, Coutinho RA, et al. Low HIV-testing rates and awareness of HIV infection among high-risk heterosexual STI clinic attendees in The Netherlands. Eur J Public Health 2008;18:376-379
11. Dukers NHTM, Fennema HS, Snoek EM van der, et al. HIV incidence and HIV testing behavior in men who have sex with men: using three incidence sources, the Netherlands, 1984-2005. AIDS 2007;21:491-499 (Pubitemid 46263260)
12. Mulder-Folkerts DKF, Hoek JAR van den, Bij AK van der, et al. Less refusal to participate in HIV screening among pregnant women in the Amsterdam region since the introduction of standard HIV screening using the opting-out method. Ned Tijdschr Geneeskd 2004;148:2035-2037 (Pubitemid 39362033)
13. Saag MS. Opt-out testing: who can afford to take care of patients with newly diagnosed HIV infection? Clin Infect Dis 2007;45:S261-5.
14. Millen JC, Arbelaez C, Walensky RP. Implications and impact of the new US Centers for Disease Control and Prevention HIV testing guidelines. Curr Infect Dis Rep 2008;10:157-163
15. Leth F, Andrews S, Grinsztejn B, et al. The effect of baseline CD4 cell count and HIV- 1 viral load on the efficacy and safety of nevirapine or efavirenz-based first-line HAART. 2NN Study Group. AIDS 2005;19:463-471 (Pubitemid 40515849)
16. Siddique MA, Hartman KE, Dragileva E, et al. Low CD4+ T cell nadir is an independent predictor of lower HIV-specific immune responses in chronically HIV-1- infected subjects receiving highly active antiretroviral therapy. J Infect Dis 2006;194:661-665 (Pubitemid 44297852)
17. Egger M, May M, Chene G, et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. ART Cohort Collaboration. Lancet 2002;360:119-129 (Pubitemid 34786200)
18. Maciosek MV, Coffield AB, Edwards NM, et al. Priorities among effective clinical preventive services: results of a systematic review and analysis. Am J Prev Med 2006;31:52-61. (Pubitemid 43956597)
19. Valdiserri RO. Late HIV diagnosis: bad medicine and worse public health. PLoS Med 2007;4:e200. (Pubitemid 46998609)
20. Dukers-Muijrers NHTM, Heijman TRLJ, van Leent EJM, et al. High time for wide application of an opting-out strategy for HIV testing. Ned Tijdschr Geneeskd 2007;151:48. (Pubitemid 350220773)
21. Galletly CL, Pinkerton SD, Petroll AE. CDC recommendations for opt-out testing and reactions to unanticipated HIV diagnoses. AIDS Patient Care STDS 2008;22:189-193